Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information

Human Pathology

Volumn 43, Issue 11, 2012, Pages 2053-2061

  Tobin, Nicholas P ^a,b   Lundgren, Katja L ^a   Conway, Catherine ^c   Anagnostaki, Lola ^d   Costello, Sean ^c   Landberg, Göran ^a,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SlidePath   (Ireland)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Automated image analysis; Cyclin D1; Invasive lobular breast carcinoma; Recurrence free survival

Indexed keywords

CYCLIN D1;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; AUTOMATION; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CARCINOMA CELL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL IMAGING; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; TISSUE MICROARRAY; TISSUE SECTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CELL NUCLEUS; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84867880533     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.02.015     Document Type: Article

References (32)

1. W.H. Wan, M.B. Fortuna, and P. Furmanski A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously J Immunol Methods 103 1987 121 129
2. R. Simon, and G. Sauter Tissue microarrays for miniaturized high-throughput molecular profiling of tumors Exp Hematol 30 2002 1365 1372
3. R. von Wasielewski, M. Mengel, and B. Wiese Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial Am J Clin Pathol 118 2002 675 682
4. I.S. Shergill, N.K. Shergill, M. Arya, and H.R. Patel Tissue microarrays: a current medical research tool Curr Med Res Opin 20 2004 707 712
5. S. Avninder, K. Ylaya, and S.M. Hewitt Tissue microarray: a simple technology that has revolutionized research in pathology J Postgrad Med 54 2008 158 162
6. C. Conway, L. Dobson, and A. O'Grady Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs Histochem Cell Biol 130 2008 447 463
7. D. Faratian, C. Kay, and T. Robson Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience Histopathology 55 2009 587 593
8. L. Dobson, C. Conway, and A. Hanley Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation Histopathology 57 2010 27 38
9. E. Rexhepaj, K. Jirstrom, and D.P. O'Connor Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer BMC Cancer 10 2010 639
10. V. Martinez, and J.G. Azzopardi Invasive lobular carcinoma of the breast: incidence and variants Histopathology 3 1979 467 488
11. G. Arpino, V.J. Bardou, G.M. Clark, and R.M. Elledge Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 2004 R149 R156
12. A.L. Bane, S. Tjan, R.K. Parkes, I. Andrulis, and F.P. O'Malley Invasive lobular carcinoma: to grade or not to grade Mod Pathol 18 2005 621 628
13. M.L. Talman, M.B. Jensen, and F. Rank Invasive lobular breast cancer. Prognostic significance of histological malignancy grading Acta Oncol 46 2007 803 809
14. G. Berx, and F. Van Roy The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression Breast Cancer Res 3 2001 289 293
15. M.J. Silverstein, B.S. Lewinsky, and J.R. Waisman Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73 1994 1673 1677
16. R.J. Santiago, E.E. Harris, L. Qin, W.T. Hwang, and L.J. Solin Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience Cancer 103 2005 2447 2454
17. B.C. Pestalozzi, D. Zahrieh, and E. Mallon Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials J Clin Oncol 26 2008 3006 3014
18. J. Kato, H. Matsushime, S.W. Hiebert, M.E. Ewen, and C.J. Sherr Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 Genes Dev 7 1993 331 342
19. S.Y. Zhang, J. Caamano, F. Cooper, X. Guo, and A.J. Klein-Szanto Immunohistochemistry of cyclin D1 in human breast cancer Am J Clin Pathol 102 1994 695 698
20. L.R. Zukerberg, W.I. Yang, and M. Gadd Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene Mod Pathol 8 1995 560 567
21. R. Naidu, N.A. Wahab, M.M. Yadav, and M.K. Kutty Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters Oncol Rep 9 2002 409 416
22. J. Mercapide, S.Y. Zhang, and X. Fan CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast Mol Carcinog 35 2002 6 12
23. T. Oyama, K. Kashiwabara, K. Yoshimoto, A. Arnold, and F. Koerner Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast Cancer Res 58 1998 2876 2880
24. R. Moll, M. Mitze, U.H. Frixen, and W. Birchmeier Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am J Pathol 143 1993 1731 1742
25. R. Michalides, P. Hageman, and H. van Tinteren A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer Br J Cancer 73 1996 728 734
26. P.J. van Diest, R.J. Michalides, and L. Jannink Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value Am J Pathol 150 1997 705 711
27. R.A. Soslow, D.L. Carlson, M.G. Horenstein, and M.P. Osborne A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas Breast Cancer Res Treat 61 2000 161 170
28. S. Lehn, N.P. Tobin, and P. Berglund Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features Am J Pathol 177 2010 2886 2897
29. F. Bienvenu, S. Jirawatnotai, and J.E. Elias Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen Nature 463 2010 374 378
30. M. Dolled-Filhart, M. Gustavson, and R.L. Camp Automated analysis of tissue microarrays Methods Mol Biol 664 2010 151 162
31. K.L. Bolton, M. Garcia-Closas, and R.M. Pfeiffer Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies Cancer Epidemiol Biomarkers Prev 19 2010 992 999
32. Z. Yu, P.M. Weinberger, and B.G. Haffty Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma Clin Cancer Res 11 2005 1160 1166